NG Peer Comparison

BSE: 530897

₹108.95

₹-0.05 (-0.05%)

As on 28-Sep-2026 11:31IST

Market cap

₹37 Cr

Revenue (TTM)

₹17 Cr

P/E Ratio

P/B Ratio

1.1

Div. Yield

3.2 %

Edit

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Market cap (₹ Cr)	37	239	128	30	28
Revenue (₹ Cr)	17	57	26	24	0
Net Profit (₹ Cr)	1.93	0.15	-0.45	-3.62	-8.72
Net Margin (%)	10.69	0.26	-1.72	-15.36	-17,442.00
RoE (%)	5.30	0.26	-3.41	--	-60.02
Price to Earnings	19.03	1,594.39	--	--	--
Price-To-Book	1.08	3.94	10.47	-11.34	2.48

Income Statement (₹ Cr)

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Operating Revenue	16.90	57.25	25.90	23.53	0.02
Total Income	18.03	58.45	26.43	23.53	0.05
Total Expenditure	15.02	52.40	24.92	25.19	8.77
EBITDA	1.88	4.85	0.99	-1.66	-8.75
Depreciation	0.57	4.57	1.58	0.52	0.00
EBIT	1.31	0.28	-0.59	-2.18	-8.75
Interest	0.06	1.25	0.39	1.36	0.00
Other Income	1.13	1.20	0.53	0.00	0.03
Exceptional Items	0.00	-0.01	0.00	0.00	0.00
Profit before Tax	2.38	0.23	-0.45	-3.54	-8.72
Provision for Tax	0.45	0.08	0.00	0.08	0.00
Profit after Tax	1.93	0.15	-0.45	-3.62	-8.72

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Shareholder's Funds	33.56	60.14	12.23	-1.23	11.75
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	0.00	13.12	3.08	12.27	0.09
Current Liabilities	1.90	9.34	3.20	15.64	2.54
Total Liabilities	41.62	69.57	17.46	22.17	15.57

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Non-Current Assets	32.40	59.70	8.97	6.70	11.84
Current Assets	2.94	11.37	4.59	17.61	2.54
Total Assets	41.62	69.57	17.46	22.17	15.57
Total Debt*	1.78	0.61	1.21	10.52	2.43
Net Current Assets	1.04	2.03	1.39	1.97	0.01
Contingent Liabilities	0.09	0.82	1.12	0.03	--

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Cash From Operating Activities	1.81	2.70	1.83	1.47	-0.23
Cash Flow from Investing Activities	-1.23	-3.99	0.12	-0.52	--
Cash from Financing Activities	-0.62	-1.60	-0.99	-0.24	0.22
Net Cash Inflow / Outflow	-0.03	-2.89	0.95	0.71	0.00

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
ROCE (%)	23.83	3.10	19.27	6.58	-1.79
ROE (%)	5.30	0.26	-3.41	-12.79	-60.02
ROA (%)	5.00	0.20	-2.52	-14.80	-121.26
EBIT Margin (%)	7.75	0.50	-2.29	-9.26	-48,627.78
Net Margin (%)	10.69	0.26	-1.72	-15.36	-17,442.00
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	-4.85

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Revenue Growth (%)	2.15	14.08	14.56	-25.05	--
EBIT Growth (%)	16.96	-40.59	-123.61	-255.13	-4.35
Net Profit Growth (%)	-74.09	-77.38	-117.74	-1,029.31	-3.83
EPS Growth (%)	-74.09	-76.43	-117.74	-1,029.31	-8.58
Book Value Growth (%)	6.59	1.00	19.94	-19.64	-2.32

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Price / Earnings	18.95	1,552.53	-294.78	0.00	-3.46
Price / Book Value	1.08	3.96	10.98	15.72	2.47
Dividend Yield (%)	3.21	0.00	0.00	0.00	0.00
EV/EBITDA	19.00	51.28	134.51	22.85	-3.23
Market Cap (₹ Cr)	54.63	145.37	87.73	20.42	--

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Debt to Equity	0.00	0.17	0.11	-9.00	0.00
Short term debt to equity ratio	0.05	--	--	0.31	0.20
Current Ratio	1.55	1.22	1.43	1.13	1.00
Quick Ratio	1.12	0.81	1.22	1.07	1.00
Interest Coverage	39.34	1.18	-0.17	-1.61	-182.25

	NG	Lotus Eye Hosp	Aspira Pathlab	Soni Medicare	Samsrita Labs
Debtors to sales (%)	2.84	2.11	6.69	54.17	111.11
Asset Turnover	0.44	0.75	1.44	0.96	0.00
Receivable days	6.31	9.50	38.11	96.98	--
Inventory Days	15.24	25.93	7.95	8.69	--
Payable days	0.00	80.52	72.32	251.51	--
Cash Conversion Cycle	21.54	-45.09	-26.26	-145.84	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.